Terms: = Leukemia AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Clinical Outcome
3 results:
1. IL-18 increases invasiveness of HL-60 myeloid leukemia cells: up-regulation of matrix metalloproteinases-9 (MMP-9) expression.
Zhang B; Wu KF; Cao ZY; Rao Q; Ma XT; Zheng GG; Li G
Leuk Res; 2004 Jan; 28(1):91-5. PubMed ID: 14630085
[TBL] [Abstract] [Full Text] [Related]
2. BAALC, a novel marker of human hematopoietic progenitor cells.
Baldus CD; Tanner SM; Kusewitt DF; Liyanarachchi S; Choi C; Caligiuri MA; Bloomfield CD; de la Chapelle A
Exp Hematol; 2003 Nov; 31(11):1051-6. PubMed ID: 14585369
[TBL] [Abstract] [Full Text] [Related]
3. Hematopoietic growth factors for the treatment of myelodysplastic syndromes.
Hansen PB; Penkowa M; Johnsen HE
Leuk Lymphoma; 1998 Feb; 28(5-6):491-500. PubMed ID: 9613978
[TBL] [Abstract] [Full Text] [Related]
